LeadIQ logo
Learn more at LeadIQ.com

Insights

Immunotherapy Innovation TheraVectys is a leading immunotherapy company leveraging lentiviral vector technology for cancer and infectious diseases treatment, presenting opportunities for partnerships in the oncology and antiviral markets.

Recent Funding Boost Recent $20M funding round signifies TheraVectys' potential for growth and expansion, indicating a readiness for new collaborations and investments in cutting-edge biotechnology solutions.

Strong Leadership Appointment Appointment of Alain Clergeot as CEO brings seasoned leadership to TheraVectys, signaling stability and vision that can be leveraged for strategic alliances and business development initiatives.

Proprietary Technology Platform TheraVectys' proprietary lentiviral vector technology offers a unique approach to immune response activation, creating opportunities for licensing agreements and technology transfer to enhance product portfolios of biopharmaceutical companies.

Strategic Market Positioning TheraVectys' focus on therapeutic vaccines aligns with growing trends in personalized medicine, opening doors for collaboration with healthcare providers and pharmaceutical firms aiming to improve patient outcomes through advanced immunotherapy solutions.

THERAVECTYS Tech Stack

THERAVECTYS uses 8 technology products and services including jsDelivr, RSS, Twitter Emoji (Twemoji), and more. Explore THERAVECTYS's tech stack below.

  • jsDelivr
    Content Delivery Network
  • RSS
    Content Management System
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Google Font API
    Font Scripts
  • OWL Carousel
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Google Maps
    Maps
  • Microsoft IIS
    Web Servers

THERAVECTYS's Email Address Formats

THERAVECTYS uses at least 1 format(s):
THERAVECTYS Email FormatsExamplePercentage
FLast@theravectys.comJDoe@theravectys.com
44%
First.Last@theravectys.comJohn.Doe@theravectys.com
11%
FMiddleLast@theravectys.comJMichaelDoe@theravectys.com
1%
FLast@theravectys.comJDoe@theravectys.com
44%

Frequently Asked Questions

Where is THERAVECTYS's headquarters located?

Minus sign iconPlus sign iconTHERAVECTYS's main headquarters is located at 28, Rue du Docteur Roux, Paris, Île-de-France 75015, FR. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is THERAVECTYS's phone number?

Minus sign iconPlus sign icon You can contact THERAVECTYS's main corporate office by phone at
+33-1-43-90-1****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is THERAVECTYS's official website and social media links?

Minus sign iconPlus sign iconTHERAVECTYS's official website is theravectys.com and has social profiles on LinkedIn.

How much revenue does THERAVECTYS generate?

Minus sign iconPlus sign icon As of May 2025, THERAVECTYS's annual revenue reached $3.8M.

What is THERAVECTYS's SIC code NAICS code?

Minus sign iconPlus sign iconTHERAVECTYS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does THERAVECTYS have currently?

Minus sign iconPlus sign iconAs of May 2025, THERAVECTYS has approximately 18 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Medical Officer: C. B.Chief Representative: A. H.Trilingual Executive Assistant To CEO: J. L.. Explore THERAVECTYS's employee directory with LeadIQ.

What industry does THERAVECTYS belong to?

Minus sign iconPlus sign iconTHERAVECTYS operates in the Biotechnology Research industry.

What technology does THERAVECTYS use?

Minus sign iconPlus sign iconTHERAVECTYS's tech stack includes jsDelivrRSSTwitter Emoji (Twemoji)Google Font APIOWL CarouselModernizrGoogle MapsMicrosoft IIS.

What is THERAVECTYS's email format?

Minus sign iconPlus sign iconTHERAVECTYS's email format typically follows the pattern of . Find more THERAVECTYS email formats with LeadIQ.

How much funding has THERAVECTYS raised to date?

Minus sign iconPlus sign icon As of May 2025, THERAVECTYS has raised $20M in funding. The last funding round occurred on Feb 08, 2021 for $20M.

When was THERAVECTYS founded?

Minus sign iconPlus sign iconTHERAVECTYS was founded in 2005.
THERAVECTYS

THERAVECTYS

Biotechnology ResearchFrance11-50 Employees

Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau.

TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs.

By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases.

Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective transfection mechanism to elicit a potent and targeted immune response previously unseen.

Section iconCompany Overview

Headquarters
28, Rue du Docteur Roux, Paris, Île-de-France 75015, FR
Phone number
+33-1-43-90-1****
Website
theravectys.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $20M

    THERAVECTYS has raised a total of $20M of funding over 4 rounds. Their latest funding round was raised on Feb 08, 2021 in the amount of $20M.

  • $10M

    THERAVECTYS's revenue is in the range of $10M

Section iconFunding & Financials

  • $20M

    THERAVECTYS has raised a total of $20M of funding over 4 rounds. Their latest funding round was raised on Feb 08, 2021 in the amount of $20M.

  • $10M

    THERAVECTYS's revenue is in the range of $10M

Company Leadership

  • Stylized image of a person
    C. B.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. H.
    Chief Representative
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Trilingual Executive Assistant To CEO
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Trilingual Executive Assistant To Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. B.
    Senior VP, Business Development
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    E. B.
    Clinical Operations Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. N.
    Senior Scientist / Project Leader In Vaccine Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. S.
    General Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. T.
    Senior Researcher In Car-T Cell Oncology Therapy, Project Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    General Manager
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.